We are pleased to announce that Calleva has joined forces with Wellma, a leading European development and manufacturing partner in the nutraceuticals and pharmaceuticals space.
Wellma is a European entity specializing in the development and manufacturing of food supplements and niche pharmaceuticals with 6 production sites across 5 European countries & global customer base. customer care, which translated into significant growth momentum over recent years.
This strategic move marks Wellma’s entry into a new important European market, the United Kingdom, complementing its broad European presence. Calleva brings unique capabilities in formulations, sourcing, excellent taste profiles, and high-quality manufacturing standards adhering to the BRC Global Standard for Food Safety, matching Wellma’s commitment to high quality, niche capabilities, and innovation.
“We believe Wellma represents a perfect fit for Calleva, both strategically and culturally” says Ed Ryle, CEO of Calleva. “On a strategic level, being part of Wellma’s ecosystem will give us access to a range of new opportunities, like a wider product portfolio and additional R&D capabilities in new product formats, which will mean an even stronger value proposition for our customers.” According to Natasha Meadows, Director at Calleva, there is a great fit also on a personal level: “We’re excited to join forces with other great, ambitious companies, and together build the leading customer offering in our space.”
“We are very excited to welcome the Calleva team to the Wellma family,” says Christian Merup, CEO of Wellma. “Calleva has impressed us from the start; high commitment to quality, strong innovation capabilities, customer focus, specialized knowledge, and a great entrepreneurial team. This is also our first company outside the European Union, which also creates opportunities for both new and existing customers of Wellma on both sides of the border. We look forward to teaming up with Ed, Natasha and the whole Calleva team going forward”.
